The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ansfield, M. J.
Right arrow Articles by Benson, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ansfield, M. J.
Right arrow Articles by Benson, B. J.

The Journal of Immunology, Vol 125, Issue 3 1093-1098, Copyright © 1980 by American Association of Immunologists

ARTICLES

Identification of the immunosuppressive components of canine pulmonary surface active material

MJ Ansfield and BJ Benson

Pulmonary surface active material (SAM), purified from canine lung lavage fluids, is a phospholipid-rich lipoprotein with potent immunosuppressive activity. Experiments were performed to identify those components of SAM that were responsible for this immunosuppressive effect. Results indicated that the lipid, and not the protein, fraction of SAM was immunosuppressive. Two phospholipids, phosphatidylglycerol and phosphatidylcholine, were identified as the predominant immunosuppressive components of the SAM-lipid fraction. lymphocyte proliferation in response to mitogenic or allogeneic stimulation was suppressed by intact SAM, SAM-lipid, phosphatidylglycerol, and phosphatidylcholine. Each of these preparations inhibited RNA, protein and DNA synthesis by mitogen- stimulated lymphocytes. Antioxidants consistently failed to diminish the immunosuppressive properties of SAM or its lipid components. The mechanism of this immunosuppressive action of SAM and its phospholipid components remains undefined. Our data indicate, however, that it is unlikely to be due either to cytotoxicity or to an artifact of lipid oxidation in vitro.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
P. J. Borron, E. A. Mostaghel, C. Doyle, E. S. Walsh, M. G. McHeyzer-Williams, and J. R. Wright
Pulmonary Surfactant Proteins A and D Directly Suppress CD3+/CD4+ Cell Function: Evidence for Two Shared Mechanisms
J. Immunol., November 15, 2002; 169(10): 5844 - 5850.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. R. Wright, P. Borron, K. G. Brinker, and R. J. Folz
Surfactant Protein A . Regulation of Innate and Adaptive Immune Responses in Lung Inflammation
Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 513 - 517.
[Full Text]

Home page
 J. Immunol.Home page
P. J. Borron, E. C. Crouch, J. F. Lewis, J. R. Wright, F. Possmayer, and L. J. Fraher
Recombinant Rat Surfactant-Associated Protein D Inhibits Human T Lymphocyte Proliferation and IL-2 Production
J. Immunol., November 1, 1998; 161(9): 4599 - 4603.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. Borron, F. X. McCormack, B. M. Elhalwagi, Z. C. Chroneos, J. F. Lewis, S. Zhu, J. R. Wright, V. L. Shepherd, F. Possmayer, K. Inchley, et al.
Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor
Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L679 - L686.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1980 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1980 by The American Association of Immunologists, Inc. All rights reserved.